/term/cash-payments/SHSE:603520 Zhejiang Starry Pharmaceutical Co (SHSE:603520) Cash Paymen
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Zhejiang Starry Pharmaceutical Co Ltd (SHSE:603520) » Definitions » Cash Payments

Zhejiang Starry Pharmaceutical Co (SHSE:603520) Cash Payments


View and export this data going back to 2016. Start your Free Trial

What is Zhejiang Starry Pharmaceutical Co Cash Payments?

Cash Payments only applicable to companies reporting Cash Flow from Operations in direct method.

Zhejiang Starry Pharmaceutical Co (SHSE:603520) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Zhejiang Starry Pharmaceutical Co Ltd (SHSE:603520) » Definitions » Cash Payments
Comparable Companies
SHSE:688247 SZSE:300485 SZSE:300110 SZSE:002644 SHSE:600488 SZSE:002393 SZSE:300194 SZSE:300401 SZSE:300636 SHSE:603998 ZTS XTER:MRK TSE:4502 LSE:HLN NSE:SUNPHARMA TSE:4523 TSE:4507 SZSE:000538 XSWX:SDZ HKSE:03692
Traded in Other Exchanges
N/A
Address
No.1 Sitali Avenue, Modern Industrial Gathering District, Zhejiang Province, Xianju County, Taizhou City, CHN, 317306
Website
http://www.starrypharm.com
Zhejiang Starry Pharmaceutical Co Ltd is engaged in R&D, manufacture and marketing of active ingredient and intermediate X-CT non-ionic contrast agent series and Fluoroquinolones series.
Executives
Hu Jin Sheng Director